
Bingchen Han, MS, PhD
- The doctor practices in an office or specialty that we currently do not survey.
- The doctor has not yet received the minimum number of patient satisfaction surveys (30) to be eligible for display.

- The doctor practices in an office or specialty that we currently do not survey.
- The doctor has not yet received the minimum number of patient satisfaction surveys (30) to be eligible for display.
Bingchen Han, MS, PhD
- The doctor practices in an office or specialty that we currently do not survey.
- The doctor has not yet received the minimum number of patient satisfaction surveys (30) to be eligible for display.

Bingchen Han, MS, PhD
Languages
- English,
Gender
Male
Experience
11 Years
Experience
Specialties
Area in which a healthcare provider is highly trained and often board certified.
1
- Research
Research Areas
The research of Bingchen Han, PhD, focuses on the cellular origin of breast cancer. The mammary stem cells and progenitor cells, which are responsible for the initial development and the subsequent maintenance of mammary gland, are thought to be vulnerable to the attacks of carcinogens and thus considered as the cellular origin of breast cancer. Understanding the molecular events in the mammary stem cells and progenitor cells is fundamental to develop new and improved therapeutic approaches for breast cancer. Dr. Han's research also focuses on the identification of the biomarkers and therapeutic targets for basal-like breast cancer, which is a breast cancer subtype with the worst prognosis.
Titles
- Assistant Professor, Surgery
Education & Training
-
Institute of Zoology, Chinese Academy of Sciences
Degrees - Completed 2011
-
Northeast Agricultural University
Degrees - Completed 2007
-
Liaocheng University
Degrees - Completed 2004
Achievements
-
6
Publications
Publications
A full list of this provider’s research publications can be found on their research profile or PubMed.
- Han BC*, Xia HF*, Sun J, Yang Y, Peng JP. Retinoic acid-metabolizing enzyme cytochrome P450 26a1 (cyp26a1) is essential for implantation: functional study of its role in early pregnancy. J Cell Physiol. 2010; 223(2):471-9. *Co-first author
- Jensen TW, Ray T, Wang J, Li X, Naritoku WY, Han B, Bellafiore F, Bagaria SP, Qu A, Cui X, et al. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay. J Natl Cancer Inst. 2015; 107(8). pii: djv148.
- Qu Y, Han B, Gao B, Bose S, Gong Y, Wawrowsky K, Giuliano AE, Sareen D, Cui X. Differentiation of Human Induced Pluripotent Stem Cells to Mammary-like Organoids. Stem Cell Reports. 2017; 8(2):205-215.
- Han B, Qu Y, Jin Y, Yu Y, Deng N, Wawrowsky K, Zhang X, Li N, Bose S, Wang Q, et al. FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer. Cell Rep. 2015; 13(5):1046-58.
- Han B, Bhowmick N, Qu Y, Chung S, Giuliano AE, Cui X. FOXC1: an emerging marker and therapeutic target for cancer. Oncogene. 2017; 36(28):3957-3963.
- Han B, Zhou B, Qu Y, Gao B, Xu Y, Chung S, Tanaka H, Yang W, Giuliano AE, Cui X. FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer. Oncogene. 2018; 37(10):1399-1408.